logo

For the Inventor, By the Inventor

Tokyo, Japan

Tokyo Metropolitan Institute of Medical Science


USPTO Granted Patents = 55



Forward Citations = 157

Loading Chart...
Loading Chart...

123 inventors (with patents filed for the assignee):

goldMedal Michinori Kohara (14 out of 19 patents)

silverMedal Takaji Wakita (10 out of 24 patents)

bronzeMedal Masato Hasegawa (6 out of 20 patents)

4.  Tomoko Date (6 out of 11 patents)

5.  Takashi Nonaka (5 out of 14 patents)

6.  Takanobu Kato (5 out of 10 patents)

7.  Jun-ichi Tanabe (5 out of 6 patents)

8.  Saburo Sone (5 out of 9 patents)

9.  Yasushi Saeki (4 out of 5 patents)

10.  Haruhiko Akiyama (4 out of 8 patents)

11.  Hitoshi Sakuraba (4 out of 7 patents)

12.  Youichi Tajima (4 out of 6 patents)

13.  Seiichi Aikawa (4 out of 6 patents)

14.  Fumiko Aikawa (4 out of 6 patents)

15.  Chise Mukaidani (3 out of 9 patents)


Core Competencies:
Hepatitis B Virus
Dengue Virus Vaccine
Tauopathies Animal Model
Antitumor Agents
Mental Retardation Treatment
Electroporation Electrodes
Ubiquitin Chain Length
Parkinson's Disease Biomarker
Neurodegenerative Diseases
Hepatitis C Virus Inhibitors
Fetal Movement Monitoring
TDP-43 Aggregates

55 patents:

1. 12458658 - Composition for inhibiting replication of hepatitis B virus (2025-11-04),
2. 12280099 - Dengue virus vaccine (2025-04-21),
3. 11895993 - Method of producing a novel animal model for tauopathies (2024-02-13),
4. 11673927 - Antitumor agent targeting HGF-regulated tyrosine kinase substrate (HGS) (2023-06-13),
5. 11642337 - Therapeutic agent for mental retardation or autism (2023-05-09),
6. 11517741 - Electrodes for electroporation (2022-12-06),
7. 11491219 - Nasal hepatitis B vaccine composition and method for producing same (2022-11-08),
8. 11339376 - Stable production of virulent enterovirus 71 and use thereof (2022-05-24),
9. 11051496 - Urokinase-type plasminogen activator transgenic mouse (2021-07-06),
10. 10634684 - Method for identifying polyubiquitinated substrate (2020-04-28),
11. 10632187 - Hemagglutinin-binding peptide (2020-04-28),
12. 10328143 - Hemagglutinin-binding peptide (2019-06-25),
13. 10327675 - Motor function analysis system and operational method of system (2019-06-25),
14. 10160979 - Pharmaceutical composition for treatment and/or prevention of hepatitis C (2018-12-25),
15. 9955675 - Urokinase-type plasminogen activator transgenic mouse (2018-05-01),
Tokyo Metropolitan Institute of Medical Science is a medical research institute located in Tokyo, Japan. It is dedicated to conducting advanced research in various medical fields and promoting medical education. The institute strives to contribute to improving medical practices and ultimately enhancing the health and well-being of the population.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

55 Patents

#667 in Tokyo

#1,582 in Japan

#12,578 in the World

...
Tokyo, Japan

Tokyo Metropolitan Institute of Medical Science

Forward Citations = 157

123 inventors:

goldMedal Michinori Kohara (14 out of 19 patents)

silverMedal Takaji Wakita (10 out of 24 patents)

bronzeMedal Masato Hasegawa (6 out of 20 patents)

4.  Tomoko Date (6 out of 11 patents)

5.  Takashi Nonaka (5 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…